Lorfast Tablet provides rapid and effective relief from symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis, and allergic skin conditions including chronic idiopathic urticaria.
It alleviates symptoms such as sneezing, nasal discharge, itching, ocular irritation, and burning. Relief of nasal and ocular symptoms typically occurs soon after oral administration.
In children over 2 years, Lorfast is indicated for the symptomatic treatment of seasonal allergic rhinitis and skin allergies like urticaria and nettlerash.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Lorfast contains Loratadine, a long-acting, non-sedative tricyclic antihistamine with selective peripheral H₁-receptor antagonistic activity. It exhibits strong antiallergic effects without causing sedation or anticholinergic side effects commonly seen with first-generation antihistamines. Loratadine acts rapidly and provides 24-hour symptom relief with once-daily dosing.
Adults and children ≥12 years: 1 tablet (10 mg) once daily, preferably in the morning or as needed.
Children 2–12 years:
Body weight >30 kg: 1 tablet (10 mg) once daily.
Body weight ≤30 kg: ½ tablet (5 mg) once daily.
Children <2 years: Not recommended due to lack of established safety and efficacy.
Symptoms of overdose in adults may include somnolence, headache, and tachycardia. In children, palpitations or extrapyramidal symptoms may occur.
Management:
Initiate symptomatic and supportive care immediately.
Administer activated charcoal if the patient presents early.
Induce emesis or perform gastric lavage in conscious patients when appropriate.
No significant or hazardous drug interactions have been reported.
Unlike many antihistamines, Lorfast does not potentiate the effects of alcohol on psychomotor performance.
Coadministration with drugs that inhibit or are metabolized by hepatic cytochrome P450 enzymes (CYP3A4 and CYP2D6)—such as cimetidine, erythromycin, or ketoconazole—may increase plasma concentrations of loratadine, but no clinically significant adverse effects have been reported.
Clinical trials have shown that the incidence of adverse effects, including sedation or anticholinergic symptoms, is comparable to placebo.
Performance studies demonstrate no impairment in driving ability, cognitive function, or psychomotor performance.
Lorfast is contraindicated in individuals with hypersensitivity to Loratadine or any of its components.
Use during pregnancy is not recommended, as adequate human data are unavailable.
Loratadine is excreted in breast milk in small amounts; therefore, nursing mothers should avoid using Lorfast.
Use cautiously in patients with hepatic impairment or severe renal insufficiency (eGFR <30 ml/min).
Dose adjustment may be considered based on clinical judgment.
Store in a cool, dry place, away from light and heat.
Keep out of the reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.